Cardiac positron emission tomography : viability, perfusion, receptors, and cardiomyopathy

著者

書誌事項

Cardiac positron emission tomography : viability, perfusion, receptors, and cardiomyopathy

edited by E.E. Van Der Wall ... [et al.]

（Developments in cardiovascular medicine, v. 166）

Kluwer Academic Publishers, c1995

大学図書館所蔵 件 / 全8件

この図書・雑誌をさがす

注記

Includes bibliographical references and index

内容説明・目次

内容説明

Myocardial viability has become an important issue in clinical cardiology. In particular, absence or presence of viability may be decisive in patient management, and the decision to perform angioplasty (PTCA) or bypass surgery (CABG) is frequently based on the accurate assessment of viability. Although echocardiography and conventional nuclear medicine techniques may provide valuable information on viability, positron emission tomography (PET) is currently considered to be the standard for the assessment of myocardial viability. The simultaneous evaluation of myocardial metabolism and perfusion allows precise delineation and accurate quantification of residual myocardial viability in affected regions. In addition, accurate quantification of myocardial perfusion alone may provide insight into the basic mechanisms of "syndrome X" and may assist in the appropriate clarification of this clinically complicated, but frequently occurring, phenomenon. Besides that, cardiac PET may deepen insight into metabolism and perfusion of cardiac muscle disease, particularly in hypertrophic cardiomyopathy. Furthermore, receptor imaging studies with PET will become important as the study of cardiac neurohumoral regulation in heart failure has gained in interest. This text describes the most recent developments in cardiac PET as these are related to myocardial viability and myocardial perfusion studies of "syndrome X". The value of PET for receptor imaging and cardiac muscle disease is also discussed.

目次

  • Part One: Myocardial Viability. 1. Myocardial viability: stunning and hibernation
  • W. Flameng, B. Shivalkar, M. Borgers. 2. Positron emission tomography assessment of myocardial viability
  • Eng-Shiong Tan. 3. Comparison of thallium scintigraphy and positron emission tomography
  • M.G. Niemeyer, J.G. Meeder, A.F.M. Kuijper, P.K. Blanksma, E.E. van der Wall. 4. Cardiac metabolism: positron emission tomography versus single photon emission computed tomography
  • E.E. van der Wall. 5. The role of fluorine-19-deoxyglucose single photon emission computed tomography in predicting reversibility of regional wall motion abnormalities after revascularization
  • J.J. Bax, J.H. Cornel, F.C. Visser, P.M. Fioretti, A. van Lingen, J.M. Huitink, O. Kamp, G.J.J. Teule, C.A. Visser. 6. Parametric positron emission tomography imaging of myocardial perfusion and metabolism
  • A.T.M. Willemsen, P.K. Blanksma, A.M.J. Paans. 7. Postron emission tomography compared to single photo emission computed tomography in the evaluation of myocardial viability: a preliminary cost-effectiveness analysis
  • M.G.M. Hunink. 8. Assessment of myocardial viability by pharmacological stress echocardiography
  • J.H. Cornel, M.P. Fioretti. 9. Assessment of myocardial viability by magnetic resonance imaging techniques
  • C.A. Schneider, F. Baer, E. Voth, P. Theissen, U. Sechtem. Part Two: Hypertrophic Cardiomyopathy. 10. Classification of hypertrophic cardiomyopathy with magnetic resonance imaging compared with echocardiography
  • J.L. Posma, P.K. Blanksma, Kong I. Lie. 11. Positron emission tomography characterization of the myocardium in hypertrophic cardiomyopathy
  • P.K. Blanksma, J.L. Posma, R.M. de Jong, J. Pruim, A.T.M. Willemsen, R.L. Anthonio, E. van der Wall, W. Vaalburg, Kong I. Lie. 12. Treatment of hypertrophic obstructive cardiomyopathy with pacing
  • L. Kappenberger, X. Jeanrenaud, N. Aebischer. Part Three: Receptor Imaging Studies. 13. Heart failure and the cardiac beta-adrenoceptor
  • O.-E. Brodde. 14. Study of cardiac receptor ligands by positron emission tomography
  • A. van Waarde, P.H. Elsinga, R.L. Anthonio, T.J. Visser, P.K. Blanksma, G.M. Visser, A.M.J. Paans, W. Vaalburg. 15. Assessment of sympathetic cardiac innervation by scintigraphic techniques
  • G. Munch, Ngoc Nguyen, D. Wieland, M. Schwaiger. 16. Experimental and clinical cardiac beta-receptor studies
  • R.L. Anthonio, A. van Waarde, A.T.M. Willemsen, J. Pruim, W.H. van Gilst, P.K. Blanksma, W. Vaalburg, Kong I. Lie. Part Four: Myocardial Perfusion. 17. Methodological issues in regional myocardial perfusion imaging with positron emission tomography
  • A. Bol, W. Wijns, J.A. Melin. (Part contents).

「Nielsen BookData」 より

関連文献： 1件中  1-1を表示

詳細情報

ページトップへ